Amgen’s Cloud Breach Exposes Patient PHI and Proprietary Data, Triggering SEC Disclosure
In July 2026 Amgen discovered unauthorized activity in third‑party cloud environments, leading to theft of protected health information and proprietary corporate data. The company filed a Form 8‑K with the SEC, noting the breach but saying it does not expect material financial impact. This highlights risks of relying on external cloud providers for sensitive biotech data.